Volume 9, Issue 5, Pages (November 2017)

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Volume 8, Issue 3, Pages (March 2017)
Volume 5, Issue 1, Pages (July 2015)
Volume 9, Issue 2, Pages (August 2017)
Volume 9, Issue 5, Pages (November 2017)
Volume 5, Issue 3, Pages (September 2015)
Volume 9, Issue 5, Pages (November 2017)
Volume 12, Issue 10, Pages (September 2015)
Volume 23, Issue 11, Pages (June 2018)
Volume 8, Issue 4, Pages (April 2017)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 8, Issue 4, Pages (April 2017)
Volume 8, Issue 3, Pages (March 2017)
Volume 9, Issue 4, Pages (October 2017)
Volume 154, Issue 6, Pages (September 2013)
Volume 7, Issue 1, Pages (April 2014)
Anupama Sahoo, Sanjaya K. Sahoo, Piyush Joshi, Bongyong Lee, Ranjan J
Molecular Therapy - Nucleic Acids
Volume 7, Issue 3, Pages (September 2016)
Molecular Therapy - Nucleic Acids
Volume 11, Issue 1, Pages (July 2018)
Volume 13, Issue 6, Pages (December 2013)
Volume 11, Issue 1, Pages (July 2018)
Volume 7, Issue 3, Pages (September 2016)
Germline Stem Cell Heterogeneity Supports Homeostasis in Drosophila
Volume 8, Issue 3, Pages (March 2017)
Volume 7, Issue 3, Pages (September 2016)
Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence
Volume 9, Issue 4, Pages (October 2017)
Volume 10, Issue 7, Pages (July 2017)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 8, Issue 4, Pages (April 2017)
Volume 1, Issue 3, Pages (September 2013)
Volume 10, Issue 3, Pages (March 2018)
Volume 9, Issue 6, Pages (December 2017)
Derivation and FACS-Mediated Purification of PAX3+/PAX7+ Skeletal Muscle Precursors from Human Pluripotent Stem Cells  Bianca Borchin, Joseph Chen, Tiziano.
Volume 9, Issue 5, Pages (November 2017)
Volume 5, Issue 5, Pages (November 2015)
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Richard A Voit, Moira A McMahon, Sara L Sawyer, Matthew H Porteus 
Volume 10, Issue 2, Pages (February 2018)
Volume 8, Issue 5, Pages (May 2017)
Volume 12, Issue 9, Pages (September 2015)
Volume 5, Issue 3, Pages (September 2015)
Volume 2, Issue 1, Pages (January 2014)
Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells  Yishai Avior, Elyad Lezmi, Dorit Yanuka, Nissim.
Volume 9, Issue 4, Pages (October 2017)
Volume 5, Issue 2, Pages (August 2015)
Volume 25, Issue 1, Pages (January 2017)
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Molecular Therapy - Nucleic Acids
Volume 13, Issue 6, Pages (November 2015)
Volume 25, Issue 2, Pages (February 2017)
Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality  Jonas Walter, Silvia Bolognin, Paul M.A.
Molecular Therapy - Nucleic Acids
Volume 23, Issue 3, Pages (March 2015)
Volume 9, Issue 4, Pages (October 2017)
Volume 17, Issue 2, Pages (August 2015)
Volume 26, Issue 6, Pages (June 2018)
Volume 16, Issue 2, Pages (February 2015)
Volume 9, Issue 4, Pages (October 2017)
Volume 5, Issue 5, Pages (November 2015)
Volume 9, Issue 6, Pages (December 2017)
Volume 13, Issue 3, Pages (October 2015)
Molecular Therapy - Nucleic Acids
DICER1 Is Essential for Self-Renewal of Human Embryonic Stem Cells
Volume 23, Issue 11, Pages (June 2018)
Volume 10, Issue 2, Pages (February 2018)
Presentation transcript:

Volume 9, Issue 5, Pages 1423-1431 (November 2017) FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling  Jonathan Arias-Fuenzalida, Javier Jarazo, Xiaobing Qing, Jonas Walter, Gemma Gomez-Giro, Sarah Louise Nickels, Holm Zaehres, Hans Robert Schöler, Jens Christian Schwamborn  Stem Cell Reports  Volume 9, Issue 5, Pages 1423-1431 (November 2017) DOI: 10.1016/j.stemcr.2017.08.026 Copyright © 2017 The Authors Terms and Conditions

Stem Cell Reports 2017 9, 1423-1431DOI: (10.1016/j.stemcr.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Figure 1 Biallelic Integration of FP-SNP Pairs Enable Deterministic Genotype Outcomes (A) Donor vectors contain a PSM expressing EGFP or dTOMATO, and an NSM expressing tagBFP. PSMs contain puromycin resistance gene (Puro). (B) Representative example of SNCAe3 polyclone 636. Random integration tagBFPpos cells are excluded from the correctly edited on-target cells tagBFPneg. (C) Theoretical distribution of populations for non-random outcomes. (D) Representative example of SNCAe3. On-target cells include homozygous populations, EGFPpos/EGFPpos or dTOMATOpos/dTOMATOpos (type 2), and heterozygous populations of undefined second-allele state EGFPpos/WT-NHEJ or dTOMATOpos/WT-NHEJ (type U). WT, wild-type. (E) Outcomes of the derived population are defined according to the donor vector design. (F) The tagBFP NSM allows removal of random integration events, assisting in the derivation of defined outcomes. Stem Cell Reports 2017 9, 1423-1431DOI: (10.1016/j.stemcr.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Figure 2 FACS Purification Increases the Speed and Yield of Isogenic Derivation (A) Post-selection sorting of double-positive biallelic edited cells for SNCAe2 and SNCAe3 using independent sgRNAs. FACS plots are represented with 2% contour lines. For SNCAe3 sgRNA-636, a dotplot is included to show the distribution of 1.2%. Diagram of knockin population types is shown (right). (B) Yield-purity and purity-purity sorting strategies permit the generation of a homogeneous biallelic knockin population. Diagram of purification population types is shown (right). (C) Representative post-sorting of single cells for SNCA polyclone. Single-cell gating structures yields high-purity biallelic edited cells. Scale bar, 50 μm. (D) Representative post-sorting culture for biallelic EGFPpos/dTOMATOpos SNCA polyclone. Scale bar, 200 μm. (E) Sanger sequencing chromatogram of SNCAe2 p.A30P polyclone 632 knockin (KI). (F) Sanger sequencing chromatogram of SNCAe3 p.A53T polyclone 636 knockin. (G) Analysis of the polyclone composition as in Figure S3. Stem Cell Reports 2017 9, 1423-1431DOI: (10.1016/j.stemcr.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Transposase-Mediated Excision of PSMs (A) FACS analysis for PSM removal. Two transfection steps of excision-only transposase result in removal of the PSMs for SNCAe2 and SNCAe3. Purification of EGFPneg/dTOMATOneg cells yields footprint-free edited lines. Diagram of removal population types is shown (right). (B) Cultures after transposase transfection for SNCAe2 present single and double PSM removal events (in arrowheads) as shown in (A). Scale bar, 200 μm. (C) Sanger sequencing chromatogram of transposed SNCAe2 p.A30P polyclone 632 and parental control. (D) Sanger sequencing chromatogram of transposed SNCAe3 p.A53T polyclone 636 and parental control. (E) Analysis of the respective polyclone composition as in Figure S3. Stem Cell Reports 2017 9, 1423-1431DOI: (10.1016/j.stemcr.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Edited SNCA Isogenic Lines Present PD-Associated Phenotypes (A) NESC differentiation protocol. (B) Microarray expression level for SNCA, TUBG1, and GAPDH in healthy control NESCs. Data represent three replicates. (C) Western blot subsequent to denaturing SDS-PAGE for α-synuclein and GAPDH for NESCs. (D) Wave plot of oxygen consumption rates for the α-synuclein isogenic set. Each wave corresponds to three biological replicates. SD of the sample is included. (E) Maximal respiration, proton leak, basal respiration, ATP production, and non-mitochondrial respiration for the extracellular energy flux analysis in (D). (F) Radar plot of fold changes for the parameters in (E). Significance levels correspond to the higher p value assigned to a mutant per category. Significance determined by unpaired Student's t-test. Significance levels are ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001; n.s., not significant. Stem Cell Reports 2017 9, 1423-1431DOI: (10.1016/j.stemcr.2017.08.026) Copyright © 2017 The Authors Terms and Conditions